These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 8455090)
1. Radiation dose to the upper spine from therapeutic administrations of iodine-131-sodium iodide. Stabin MG J Nucl Med; 1993 Apr; 34(4):695-6. PubMed ID: 8455090 [TBL] [Abstract][Full Text] [Related]
2. Iodine-131 in breast milk following therapy for thyroid carcinoma. Robinson PS; Barker P; Campbell A; Henson P; Surveyor I; Young PR J Nucl Med; 1994 Nov; 35(11):1797-801. PubMed ID: 7965159 [TBL] [Abstract][Full Text] [Related]
3. Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe? de Carvalho JW; Sapienza M; Ono C; Watanabe T; Guimarães MI; Gutterres R; Marechal MH; Buchpiguel C Nucl Med Commun; 2009 Jul; 30(7):533-41. PubMed ID: 19436231 [TBL] [Abstract][Full Text] [Related]
4. Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal. Hänscheid H; Lassmann M; Luster M; Thomas SR; Pacini F; Ceccarelli C; Ladenson PW; Wahl RL; Schlumberger M; Ricard M; Driedger A; Kloos RT; Sherman SI; Haugen BR; Carriere V; Corone C; Reiners C J Nucl Med; 2006 Apr; 47(4):648-54. PubMed ID: 16595499 [TBL] [Abstract][Full Text] [Related]
5. The effects of dialysis on 131I kinetics and dosimetry in thyroid cancer patients--a pharmacokinetic model. Pahlka RB; Sonnad JR Health Phys; 2006 Sep; 91(3):227-37. PubMed ID: 16891898 [TBL] [Abstract][Full Text] [Related]
6. [Cytogenetic study of thyroid patients treated with external irradiation or radioiodine]. Katz N; Esik O; Füzy M; Gundy S Orv Hetil; 1998 Jun; 139(25):1521-6. PubMed ID: 9676113 [TBL] [Abstract][Full Text] [Related]
7. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone. Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259 [TBL] [Abstract][Full Text] [Related]
8. Radioactive iodine in thyroid medicine--how it started in Sweden and some of today's challenges. Mattsson S; Johansson L; Jönsson H; Nosslin B Acta Oncol; 2006; 45(8):1031-6. PubMed ID: 17118834 [TBL] [Abstract][Full Text] [Related]
9. Correlation between external exposure and activity in patients undergoing 131I thyroid cancer therapy. Barquero R; Basurto F; Vega-Carrillo HR; Iñiguez MP; Ferrer N; Esteban R Health Phys; 2008 Aug; 95(2):227-33. PubMed ID: 18617804 [TBL] [Abstract][Full Text] [Related]
10. A minimally invasive method to evaluate 131I kinetics in blood. Traino AC; Di Martino F; Boni G; Mariani G; Lazzeri M Radiat Prot Dosimetry; 2004; 109(3):249-52. PubMed ID: 15254330 [TBL] [Abstract][Full Text] [Related]
11. Use of a voxel phantom as a source and a second voxel phantom as a target to calculate effective doses in individuals exposed to patients treated with 131I. de Carvalho AB; Hunt J; Silva AX; Garcia F J Nucl Med Technol; 2009 Mar; 37(1):53-6. PubMed ID: 19223425 [TBL] [Abstract][Full Text] [Related]
12. Radiation dosimetry for the adult female and fetus from iodine-131 administration in hyperthyroidism. Stabin MG; Watson EE; Marcus CS; Salk RD J Nucl Med; 1991 May; 32(5):808-13. PubMed ID: 2022987 [TBL] [Abstract][Full Text] [Related]
14. Iodide kinetics and dosimetry in vivo after transfer of the human sodium iodide symporter gene in rat thyroid carcinoma cells. Haberkorn U; Beuter P; Kübler W; Eskerski H; Eisenhut M; Kinscherf R; Zitzmann S; Strauss LG; Dimitrakopoulou-Strauss A; Altmann A J Nucl Med; 2004 May; 45(5):827-33. PubMed ID: 15136633 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic 131I in outpatients: a simplified method conforming to the Code of Federal Regulations, title 10, part 35.75. Coover LR; Silberstein EB; Kuhn PJ; Graves MW J Nucl Med; 2000 Nov; 41(11):1868-75. PubMed ID: 11079497 [TBL] [Abstract][Full Text] [Related]
16. Radioiodine treatment of hyperthyroidism in a pregnant women. Berg GE; Nyström EH; Jacobsson L; Lindberg S; Lindstedt RG; Mattsson S; Niklasson CA; Norén AH; Westphal OG J Nucl Med; 1998 Feb; 39(2):357-61. PubMed ID: 9476950 [TBL] [Abstract][Full Text] [Related]
17. Glycophorin A as a biological dosimeter for radiation dose to the bone marrow from iodine-131. Jensen RH; Reynolds JC; Robbins J; Bigbee WL; Grant SG; Langlois RG; Pineda JD; Lee T; Barker WC Radiat Res; 1997 Jun; 147(6):747-52. PubMed ID: 9189175 [TBL] [Abstract][Full Text] [Related]
18. Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I. Pant GS; Sharma SK; Bal CS; Kumar R; Rath GK Radiat Prot Dosimetry; 2006; 118(1):22-7. PubMed ID: 16105892 [TBL] [Abstract][Full Text] [Related]
19. Radiation safety protocol for high dose 131I therapy of thyroid carcinoma in patients on hemodialysis for chronic renal failure. Modarresifar H; Almodovar S; Bass WB; Ojha B Health Phys; 2007 Feb; 92(2 Suppl):S45-9. PubMed ID: 17228187 [TBL] [Abstract][Full Text] [Related]
20. New horizons for therapeutic nuclear medicine in 1981. Beierwaltes WH J Nucl Med; 1981 Jun; 22(6):549-54. PubMed ID: 7229726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]